4basebio LSE:4BB is among the notable UK-listed market movers on 21 September 2026, with the stock shown4.17% higher.
Abingdon Health LSE:ABDX is among the notable movers shown on 21 September 2026, with the share price gaining4.76%.
AOTI LSE:AOTI is attracting attention after rising3.85% on 21 September 2026, with investors continuing to follow developments surrounding the company's TWO2 topical oxygen therapy platform and its potential expansion across the US healthcare market.
Arecor Therapeutics LSE:AREC is among the notable movers shown on 21 September 2026, with the stock gaining4.47%.
Cambridge Nutritional Sciences LSE:CNSL is among the notable UK market movers on 21 September 2026, with the share price shown3.57% higher.
Ondine Biomedical shares rose by 4.37% as investors continued to assess the implications of positive topline results from the pivotal LANTERN study. The trial achieved its primary efficacy objective, demonstrating that nasal photodisinfection used alongside standard care reduced the risk of surgical-site infections compared …
Genflow Biosciences shares rose by 4.10% as investors continued to assess the positive outcome from the company’s SLAB veterinary longevity trial. The study evaluated Genflow’s proprietary SIRT6 centenarian gene therapy in aged dogs and achieved its primary objective of reducing biological age as measured …
AMS designs, develops and manufactures a range of medical products, notably its tissue-adhesive products used to close wounds and surgical incisions, alongside sutures, sealants and advanced wound-care dressings. It sells both its own branded products and products supplied to partner companies. These are consumable …
Agronomics builds a portfolio of holdings in companies pioneering cellular agriculture, the production of animal products such as meat and dairy, and related materials, using cell-culture and fermentation techniques instead of conventional farming. The thesis is that these approaches could, over time, offer more …
Allergy Therapeutics develops and sells treatments that aim to tackle the cause of allergies through immunotherapy,Trainingthe immune system to tolerate allergens rather than merely suppressing symptoms. The company markets established products in several European countries and has been advancing a pipeline that includes a …